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Abstract
It has been generally accepted that the mammalian embryo starts its development with all cells
identical and only when inside and outside cells form do differences between cells first emerge.
However, recent findings show that cells in the mouse embryo can differ in their developmental
fate and potency already by the 4-cell-stage1-4. Such differences depend on the orientation and
order of the cleavage divisions that generated them2,5. Since epigenetic marks are suggested to be
involved in sustaining pluripotency6,7, we considered that such developmental properties might be
achieved through epigenetic mechanisms. Here, we show that modification of histone H3, through
methylation of specific arginine residues, correlates with cell fate and potency. Levels of H3
methylation at specific arginines are maximal in 4-cell blastomeres that will contribute to the ICM
and polar trophectoderm and undertake full development when combined together in chimeras.
Arginine methylation of H3 is minimal in cells whose progeny contributes more to the mural
trophectoderm and that show compromised development when combined in chimeras. This
suggests that higher levels of H3 arginine methylation predispose blastomeres to contribute to the
pluripotent cells of the ICM. We confirm this prediction by overexpressing the H3-specific
arginine methyltransferase, CARM1, in individual blastomeres and show this directs their progeny
to the ICM and results in a dramatic upregulation of Nanog and Sox2. Thus, our results identify
specific histone modifications as the earliest known epigenetic marker contributing to
development of ICM and show that manipulation of epigenetic information influences cell fate
determination.
To address whether epigenetic differences exist between blastomeres at the 4-cell stage, we
focused on histone methylation marks related to transcriptional activation8-10. Because the
divisions of 2-cell-stage blastomeres differ in orientation in relation to the animal-vegetal
axis of the egg5,11, the shape of 4-cell embryos vary: blastomeres fill the apices of a
tetrahedron when they undergo one equatorial (E) and one meridional (M) division or they
lie upon a similar plane when they undergo either two equatorial or two meridional divisions
(Fig. 1a). Although any combination of the temporal sequence of such divisions is possible,
sequential M and E divisions are most common (~80%), but they can occur in either order.
We found that whereas embryos that underwent either two equatorial or two meridional
divisions did not show significant variations in the levels of H3 methylation at arginine 26
(H3R26me) between 4-cell-stage blastomeres. (Fig. 1a, EE&MM embryos; blue bars),
tetrahedral embryos displayed marked differences in H3R26me levels between their
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blastomeres (Fig.1a, EM & ME embryos; red bars). In the latter, the weakest level of
H3R26me was generally less than 40% of the cell giving the strongest signal (p=0.0002).
Measuring the intensity of DNA staining indicated that the variation of H3R26me levels was
not related to differences in the content of DNA due to replication (not shown). We
confirmed that this variation in H3R26me levels did not result from the confocal scanning of
embryos of differing shapes by scanning individual cells of disaggregated embryos, where
we found a similar outcome (Supplementary Figure S1). In addressing whether the
methylation of other arginines also showed differences between 4-cell blastomeres, we
found that levels of H3R2me and H3R17me (Supplementary Figures S2-S3a) varied
between blastomeres correlating with embryo morphology in a similar way to H3R26me.
This is consistent with R2 and R17 being targets for the same methyltransferase, CARM1,
as R2612,13.
When we analysed CARM1 distribution in 4-cell blastomeres, we found that CARM1 levels
varied with the same tendency as those of H3R26me (Supplementary Figure S4b-c). In
contrast, methylation of H4R3, which is target of a different methyltransferase, PRMT114,15,
appeared equivalent between blastomeres regardless of embryo morphology (Fig. 1b). Thus,
the differences in the levels of histone arginine methylation in 4-cell-stage blastomeres are
specific. We also observed that levels of BrUTP incorporation in late 4-cell-stage embryos
were highest in the blastomeres that are enriched for H3R26me, indicative of elevated levels
of global transcription in these cells (Fig. 1c-e). Since H3R26me showed the biggest
difference in its distribution between blastomeres (Supplementary Figure S3b), we
concentrated on analyzing this modification further.
As different developmental fate and potential can be ascribed to blastomeres depending
upon the orientation and the order of division from the 2- to the 4-cell-stage in relation to the
animal-vegetal axis, we wished to determine whether differences in H3R26me related to
patterns of division. To this end we first grouped embryos according to their cleavage
patterns to the 4-cell-stage. When the earlier of the second cleavages is M and the later E
(ME embryos), the earlier dividing 2-cell blastomere contributes most of its progeny to the
embryonic (ICM and adjacent polar trophectoderm) and the later one to the abembryonic
part (ICM and mural trophectoderm) of the blastocyst. When the earlier second cleavage is
E and the later M (EM embryos), the earlier blastomere can give rise to either the embryonic
or abembryonic part of the blastocyst. By contrast, when second cleavage divisions are of
similar orientation (MM or EE), the allocation of blastomere progeny is random. The ME
group of embryos thus allowed the identification of individual 4-cell blastomeres that have
predictable fate within the blastocyst5. Moreover, blastomeres resulting from the E division
that inherit the “vegetal” cytoplasm in ME embryos tend to contribute predominantly to the
mural trophectoderm and do not complete development when combined with the same type
of “vegetal” cells in chimeric embryos2. In contrast, chimaeras of blastomeres that arise
from early M divisions (with ‘animal–vegetal’ cytoplasm) could complete development with
full success and chimeras constructed only from ‘animal’ blastomeres could also develop
although with reduced success. To distinguish the progeny of 2-cell-stage blastomeres, we
injected one 2-cell blastomere at random with rhodamine-dextran and then monitored the
second cleavage divisions (Supplementary Figure S5a). Immunostaining then revealed
similar levels of H3R26me in the progeny of both E and M divisions of EM embryos
(compare M cells vs E cells; Supplementary Figure S5b-c; p=0.112). In ME embryos,
however, the M sister cells displayed significantly higher levels of H3R26 methylation than
both E sisters, with one of the E-derived blastomeres displaying significantly less
methylation than either of the M-derived blastomeres (Supplementary Figure S5b-c; p
<0.0001). In confirmation of our earlier observations (Fig.1), EE or MM embryos did not
display differences in their relative H3R26me levels. Thus, in ME embryos where prediction
of developmental properties is possible, higher levels of H3R26me are seen in blastomeres
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expected to contribute to the embryonic part of the blastocyst and lower levels in
blastomeres expected to contribute to the abembryonic part.
Given the reported differences in developmental potential of “animal” or “vegetal”
blastomeres arising from E divisions in ME embryos2, we next examined whether these cells
differed in their H3R26me levels. To this end we randomly injected a 2-cell-stage
blastomere with rhodamine-dextran as before and then applied green fluorescent beads to
the vegetal membranes of the two blastomeres as a second label (Fig. 2a and Ref.2). The
rhodamine label allowed us to score the order and the plane of division to the 4-cell-stage
and the beads served as ‘vegetal’ markers. We found that in ME embryos, the ‘vegetal’
blastomere always displayed significantly lower levels of H3R26me than the “animal” or
“animal/vegetal” blastomeres (Fig. 2b; p <0.0001). In contrast, in EM embryos the ‘animal’
and ‘vegetal’ blastomeres from the E division displayed equivalent levels of H3R26me (Fig.
2b). Taken together our results indicate that more extensive H3 arginine methylation in M
blastomeres of ME embryos correlates with their greater contribution to the embryonic part
of the blastocyst. In contrast, blastomeres having the lowest levels of H3 arginine
methylation (i.e. ‘vegetal’ blastomeres) are those predicted to contribute mainly to the
abembryonic part.
As levels of methylation at arginines 2, 17 and 26 varied similarly and as these three
residues are the specific targets of CARM1/PRMT4, which is expressed maternally in
mouse embryos (Supplementary Figures S4,S6), we wondered whether CARM1 might play
a role in directing developmental fate and potency. To test this, we injected CARM1 mRNA
into single late 2-cell-stage blastomeres aiming to elevate levels of H3 arginine methylation
in the progeny of these cells from the mid 4-cell-stage. We followed the effect upon cell fate
by co-injecting mRNA for DsRed as lineage tracer (Fig.3a-b). Strikingly, the labeled clone
was located in the embryonic part of the blastocyst in 31 out of 35 embryos (89%) and in no
embryos labeled cells were found exclusively in the abembryonic part. We randomly
selected 10 of these embryos to reconstruct in 3 dimensions to locate every cell and
determine to which lineage (ICM or trophectoderm) labelled cells had contributed. This
showed that the ICM comprised 37% of all cells at this stage and that on average, 88.5% of
ICM cells were derived from the blastomere in which CARM1 had been overexpressed (Fig.
3d, Fig.3e, Supplementary Table S1). Notably, in half of the embryos, all of the ICM
comprised the exclusive progeny of the CARM1-overexpressing blastomere. By contrast,
even though the majority (63%) of the blastocyst cells are outer cells, the proportion of outer
cells derived from the CARM1-overexpressing blastomere was only 12% (Fig.3e,
Supplementary Table S1). This was contrasted to control embryos, injected with mRNA for
DsRed only, where we found that 41% and 59% of cells labeled with the lineage tracer were
inner or outer cells, respectively (p<0.0001)(Fig.3e and Supplementary Table S2). Thus, we
conclude that forced overexpression of CARM1 in a 2-cell blastomere leads that cell to
contribute predominantly (if not exclusively) to the ICM. To establish whether the
methyltransferase activity of CARM1 was required for this effect, we injected mRNA for
CARM1, which contains a point mutation (E267Q) and is devoid of catalytic activity16 into
single 2-cell blastomeres as above. We found that the progeny of the labelled cells could
contribute to both embryonic and abembryonic regions of the blastocyst. The distribution of
the progeny of the CARM1(E267Q)-injected blastomere was similar to the DsRed control
(Fig.3e, Supplementary Table S3, Fig.3d). The progeny of the CARM1-overexpressing
blastomere displayed increased levels of H3R26me whereas blastomeres overexpressing
CARM1(E267Q) did not (Fig.4a-b). Hence, the ability of CARM1 to direct the progeny of a
blastomere towards the ICM is strictly dependent on its methyltransferase activity.
We next assessed expression levels of transcription factors known to influence the
development of ICM cells. Interestingly, we found that overexpression of CARM1 led to an
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early and dramatic upregulation of Nanog in the injected blastomeres, suggesting that the
Nanog promoter is regulated by arginine methylation (Fig. 4c). In contrast, Cdx2, a
trophectoderm marker, showed no induction upon CARM1 overexpression (not shown). We
also detected increased levels of Sox2 in the progeny of the CARM1-injected blastomere
(Fig. 4c). However, Oct4/Pou5f1 showed variable levels of expression in non-injected
blastomeres as well as in CARM1 overexpressing cells (Supplementary Figure S7). Note
that, in contrast to Nanog, both Oct4/Pou5f1 and Sox2 were also present in the non-injected
blastomeres reflecting an earlier expression and/or their maternal inheritance17,18. The co-
expression by the blastocyst stage of the ICM markers Oct4/Pou5f1 and Nanog in the
progeny of the CARM1-overexpressing blastomere is consistent with the observed change in
cell fate (Fig.4d). Hence, by manipulating epigenetic information through overexpression of
a histone modifier it is possible to direct cells towards the ICM.
Our findings, in control experiments, that either of the 2-cell blastomeres normally
contributes their progeny to inner or outer cells of the blastocyst is in accordance with our
earlier findings1,2,4,5. However, it contrasts to a report that shows that as a consequence of
differential Cdx2 levels between 2-cell blastomeres, one blastomere contributes exclusively
to outer cells, which normally express Cdx219. Unlike these authors we do not observe
expression of Cdx2 at the 2-cell-stage.
Our study provides the first demonstration that epigenetic differences develop between
blastomeres by the 4-cell-stage. We cannot exclude the possibility that CARM1 mediates
some of its effects through targets other than histone H3. However, the differential levels of
H3 methylation between 4-cell blastomeres can account for their different cell fate and
potency1,4,5. Cells with more extensive H3 arginine methylation are destined to contribute
pluripotent progeny to the blastocyst. These cells show increased levels of transcription that
includes expression of a select set of genes responsible for maintaining pluripotency such as
Nanog and Sox218,20,21. An enrichment in modifications characteristic of euchromatin may
have additional effects upon the chromatin to generate an “open” configuration that could
sustain pluripotency in the embryo as has been suggested for ES cells22. Indeed, the relative
importance of potential changes in chromatin structure in relation to cell plasticity demands
further study.
Methods
Embryos were collected from F1 crosses (C57BL/6XCBA/H). To monitor the division from
the 2-cell-stage, one blastomere was microinjected randomly with Dextran-
tetramethylrhodamine (3000MW,Molecular Probes). Green fluorescent beads were placed in
the membrane of blastomeres using a Piezo driller. Embryos were observed every 20
minutes to determine the plane and order of division5. Immunostaining and BrUTP labelling
were performed as described23. H3 asymmetric-dimethyl-R2, H3 dimethyl-R17, H3
dimethyl-R26, H4 symmetric-dimethyl-R3 antibodies were from abcam (Supplementary
Figure S9); Oct4 from R&D systems; NANOG and Sox2 from Santa Cruz. For analysis of
4-cell embryos, confocal sections were taken every 0.8μm through the whole embryo and
fluorecsence signal was measured in projections using the Volocity software (Improvision).
For 3D reconstructions, blastocysts were stained with phallaoidin-Texas-Red and TOTO-3.
Confocal sections were captured every 1μm and processed with IMARIS (Bitplane) and
3DVirtual Embryo software24.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Levels of H3R26me are different in blastomeres of 4-cell stage embryos and correlate with
their spatial arrangement.
(a) 4-cell stage embryos were stained for H3R26me and grouped according to their shape in
tetrahedral (EM and ME), EE (flatten,polar body on one side) or MM (flatten,polar body in
the middle). Shown are projections, including all sections, of representative
embryos.Fluorescence levels were quantified and normalised against the blastomere
showing the highest level which was set at 100%. Decreasing values of fluorescence were
normalised and averaged accordingly(n=18). Each bar represents the relative fluorescence
level of each of the 4 blastomeres. Scale bar 50μm.
(b) Differences in histone arginine methylation levels in 4-cell stage blastomeres are
specific:only residues that are CARM1 targets, and not PRMT1, display differential
distribution.
(c) 4-cell stage blastomeres display different global transcriptional activity. BrUTP
incorporation was measured in sections from nuclei of 4-cell stage embryos captured every
0.6μm (n=12). Projections were used after cropping off the nuclei using the Volocity
software to quantify active (nuclear) transcription. Values were normalised as in (a).
(d-e) Global transcription levels correlate with global H3R26me levels. Quantification (d) of
BrUTP incorporation (green) and H3R26me (red) of 4-nuclei of a representative embryo.
Nuclei (e) are shown at the same scale,numbers at the bottom correspond to the blastomere
numbers of the graph.
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Figure 2.
The ‘vegetal’ blastomere in ME embryos displays the lowest levels of H3R26me.
(a) Design to determine the identity of 4-cell-stage blastomeres according to division
orientation, order, and blastomere positioning. A 2-cell stage blastomere was microinjected
with rhodamine-dextran. We then placed a green fluorescent bead in the ‘vegetal’ membrane
of the two blastomeres. Divisions were scored and embryos were stained for H3R26me at
the late 4-cell stage.The position of the bead and the presence of rhodamine allowed
identification of the blastomeres as Animal/Vegetal (A/V,derived from M divisions),
Animal or Vegetal (A or V,derived from E divisions) in EM(n=10) or ME(n=9) embryos.
(b) The vegetal blastomere of ME embryos displays the lowest levels of H3R26me while the
vegetal blastomere of EM embryos displays similar levels to the animal or animal/vegetal
blastomeres. H3R26me levels were quantified as in Fig.1.
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Figure 3.
CARM1 overexpression in a 2-cell blastomere results in the contribution of that cell
predominantly to the ICM.
A late 2-cell stage blastomere was injected with mRNA for DsRed alone (control) or in
combination with mRNA for CARM1.HA. This results in CARM1 overexpression from the
mid 4-cell stage since CARM1.HA/DsRed expression starts 6-8h after injection (not shown).
Embryos were cultured until the blastocyst stage and observed under fluorescence
microscopy. DsRed was used as a lineage tracer.
(a) Representative embryos derived from DsRed only (n=17) or DsRed/CARM1.HA-
overexpression experiments (n=35).
(b) Blastocysts were stained with phallaoidin-Texas-Red and TOTO-3 (to visualize cell
membranes and DNA, respectively) and analysed under confocal microscopy.
Representative top, middle and bottom sections are shown. DNA is in blue; Phallaoidin (red)
can be distinguished from DsRed because the latter is exclusively cytoplasmic. The red
channel is shown as grayscale. The progeny of the CARM1-overexpressing blastomere is
predominantly within the inner cells of the blastocyst.
(c) Overexpression of CARM1 was verified by Western blot in zygotes injected with mRNA
for CARM1.HA/DsRed.
(d) Representative 3D reconstructions of blastocysts in which mRNA for CARM1.HA/
DsRed (a), Ds/Red only (d), or CARM1(E267Q).HA/DsRed (g) was microinjected at the 2-
cell stage. Blastocysts were stained as in (b). Confocal z-stacks were taken at 1μm intervals.
IMARIS software was used to outline cell membranes to create 3D models of all cells of the
embryo. Cells were then scored according to their position: cells completely surrounded by
others are denoted as inner, those with an outer surface as outer. Cells were scored as either
positive or negative for DsRed. Progeny of injected blastomere is shown in red. A middle
slice is shown in b,e, h where the cavity is depicted with a line. In c,f ,i, only the progeny of
the injected blastomere is shown, the contour of the embryo is indicated by a dashed line and
the position of the cavity by a solid line. Scale bar 10μm.
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Figure 4.
Overexpression of CARM1 results in elevated levels of arginine methylation and
upregulation of Nanog and Sox2.
(a-b) A 2-cell stage blastomere was injected with mRNA for CARM1.HA/DsRed. Embryos
were cultured to the 8-cell stage and stained for H3R26me. Shown are 3 nuclei of cells from
a representative embryo. The progeny of the injected blastomere is indicated by arrows (note
the presence of DsRed). In (b) H3R26me levels in cells overexpressing CARM1 were
normalised against those of non-injected cells within the same embryo (*p=0.0006)(n=14).
In the bottom, data derived from overexpression of CARM1(E267Q).HA. Here, 5 cells from
the same embryo are shown(n=6). PB:polar body.
(c) Embryos were injected as in (a) and stained with a NANOG (n=5) or a Sox2 (n=11)
antibody between the 6- and 8-cell stage. For NANOG, 4 nuclei of the same embryo, two of
them deriving from the CARM1-overexpressing blastomere are shown(white arrows, note
the presence of DsRed). NANOG is detectable only in the blastomeres deriving from the 2-
cell stage blastomere injected with CARM1 mRNA. For Sox2, a representative embryo is
shown. Note that Sox2 is mainly cytoplasmic at this stage18. We were unable to address
CARM1 function by the converse experiment by RNAi since the protein is provided
maternally and its mRNA is rapidly downregulated after fertilization. However, treatment of
zygotes with specific arginine methyltransferase inhibitors25 showed that reducing levels of
histone arginine methylation impaired development (Supplementary Figure S8).
(d) The progeny of CARM1-overexpressing blastomere expresses ICM markers in the
blastocyst. Blastocysts were stained for Oct4/Pou5f1 (n=7) or NANOG (n=3)(green). The
presence of DsRed indicates the progeny of the injected blastomere. DNA shown in blue.
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